Global Human Microbiome Supply, Demand and Key Producers, 2024-2030

Description

The global Human Microbiome market size is expected to reach $ 1483.8 million by 2030, rising at a market growth of 20.8% CAGR during the forecast period (2024-2030).

At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.

An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

This report studies the global Human Microbiome demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Microbiome, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Microbiome that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Microbiome total market, 2019-2030, (USD Million)
Global Human Microbiome total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Human Microbiome total market, key domestic companies and share, (USD Million)
Global Human Microbiome revenue by player and market share 2019-2024, (USD Million)
Global Human Microbiome total market by Type, CAGR, 2019-2030, (USD Million)
Global Human Microbiome total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Human Microbiome market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd and Enterologics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Microbiome market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Human Microbiome Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Microbiome Market, Segmentation by Type
    Gastrointestinal Tract Human Micobiome
    Urogenital Tract Human Micobiome
    Others

Global Human Microbiome Market, Segmentation by Application
    Treatment
    Diagnosis

Companies Profiled:
    Vedanta
    Seres Therapeutics
    Second Genome
    Rebiotix
    ActoGeniX
    Enterome BioScience
    AvidBiotics
    4D Pharma Research Ltd
    Enterologics
    Metabogen
    Metabiomics
    Ritter Pharmaceuticals
    Osel
    Symberix
    Miomics
    Symbiotix Biotherapies
    MicroBiome Therapeutics LLC

Key Questions Answered
1. How big is the global Human Microbiome market?
2. What is the demand of the global Human Microbiome market?
3. What is the year over year growth of the global Human Microbiome market?
4. What is the total value of the global Human Microbiome market?
5. Who are the major players in the global Human Microbiome market?

Table of Contents

1 Supply Summary
    1.1 Human Microbiome Introduction
    1.2 World Human Microbiome Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Human Microbiome Total Market by Region (by Headquarter Location)
        1.3.1 World Human Microbiome Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Human Microbiome Market Size (2019-2030)
        1.3.3 China Human Microbiome Market Size (2019-2030)
        1.3.4 Europe Human Microbiome Market Size (2019-2030)
        1.3.5 Japan Human Microbiome Market Size (2019-2030)
        1.3.6 South Korea Human Microbiome Market Size (2019-2030)
        1.3.7 ASEAN Human Microbiome Market Size (2019-2030)
        1.3.8 India Human Microbiome Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Microbiome Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Microbiome Major Market Trends

2 Demand Summary
    2.1 World Human Microbiome Consumption Value (2019-2030)
    2.2 World Human Microbiome Consumption Value by Region
        2.2.1 World Human Microbiome Consumption Value by Region (2019-2024)
        2.2.2 World Human Microbiome Consumption Value Forecast by Region (2025-2030)
    2.3 United States Human Microbiome Consumption Value (2019-2030)
    2.4 China Human Microbiome Consumption Value (2019-2030)
    2.5 Europe Human Microbiome Consumption Value (2019-2030)
    2.6 Japan Human Microbiome Consumption Value (2019-2030)
    2.7 South Korea Human Microbiome Consumption Value (2019-2030)
    2.8 ASEAN Human Microbiome Consumption Value (2019-2030)
    2.9 India Human Microbiome Consumption Value (2019-2030)

3 World Human Microbiome Companies Competitive Analysis
    3.1 World Human Microbiome Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Human Microbiome Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Human Microbiome in 2023
        3.2.3 Global Concentration Ratios (CR8) for Human Microbiome in 2023
    3.3 Human Microbiome Company Evaluation Quadrant
    3.4 Human Microbiome Market: Overall Company Footprint Analysis
        3.4.1 Human Microbiome Market: Region Footprint
        3.4.2 Human Microbiome Market: Company Product Type Footprint
        3.4.3 Human Microbiome Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Human Microbiome Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Human Microbiome Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Human Microbiome Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Human Microbiome Consumption Value Comparison
        4.2.1 United States VS China: Human Microbiome Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Human Microbiome Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Human Microbiome Companies and Market Share, 2019-2024
        4.3.1 United States Based Human Microbiome Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Human Microbiome Revenue, (2019-2024)
    4.4 China Based Companies Human Microbiome Revenue and Market Share, 2019-2024
        4.4.1 China Based Human Microbiome Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Human Microbiome Revenue, (2019-2024)
    4.5 Rest of World Based Human Microbiome Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Human Microbiome Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Human Microbiome Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Human Microbiome Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Gastrointestinal Tract Human Micobiome
        5.2.2 Urogenital Tract Human Micobiome
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Human Microbiome Market Size by Type (2019-2024)
        5.3.2 World Human Microbiome Market Size by Type (2025-2030)
        5.3.3 World Human Microbiome Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Human Microbiome Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Treatment
        6.2.2 Diagnosis
    6.3 Market Segment by Application
        6.3.1 World Human Microbiome Market Size by Application (2019-2024)
        6.3.2 World Human Microbiome Market Size by Application (2025-2030)
        6.3.3 World Human Microbiome Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Vedanta
        7.1.1 Vedanta Details
        7.1.2 Vedanta Major Business
        7.1.3 Vedanta Human Microbiome Product and Services
        7.1.4 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Vedanta Recent Developments/Updates
        7.1.6 Vedanta Competitive Strengths & Weaknesses
    7.2 Seres Therapeutics
        7.2.1 Seres Therapeutics Details
        7.2.2 Seres Therapeutics Major Business
        7.2.3 Seres Therapeutics Human Microbiome Product and Services
        7.2.4 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Seres Therapeutics Recent Developments/Updates
        7.2.6 Seres Therapeutics Competitive Strengths & Weaknesses
    7.3 Second Genome
        7.3.1 Second Genome Details
        7.3.2 Second Genome Major Business
        7.3.3 Second Genome Human Microbiome Product and Services
        7.3.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Second Genome Recent Developments/Updates
        7.3.6 Second Genome Competitive Strengths & Weaknesses
    7.4 Rebiotix
        7.4.1 Rebiotix Details
        7.4.2 Rebiotix Major Business
        7.4.3 Rebiotix Human Microbiome Product and Services
        7.4.4 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Rebiotix Recent Developments/Updates
        7.4.6 Rebiotix Competitive Strengths & Weaknesses
    7.5 ActoGeniX
        7.5.1 ActoGeniX Details
        7.5.2 ActoGeniX Major Business
        7.5.3 ActoGeniX Human Microbiome Product and Services
        7.5.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 ActoGeniX Recent Developments/Updates
        7.5.6 ActoGeniX Competitive Strengths & Weaknesses
    7.6 Enterome BioScience
        7.6.1 Enterome BioScience Details
        7.6.2 Enterome BioScience Major Business
        7.6.3 Enterome BioScience Human Microbiome Product and Services
        7.6.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Enterome BioScience Recent Developments/Updates
        7.6.6 Enterome BioScience Competitive Strengths & Weaknesses
    7.7 AvidBiotics
        7.7.1 AvidBiotics Details
        7.7.2 AvidBiotics Major Business
        7.7.3 AvidBiotics Human Microbiome Product and Services
        7.7.4 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 AvidBiotics Recent Developments/Updates
        7.7.6 AvidBiotics Competitive Strengths & Weaknesses
    7.8 4D Pharma Research Ltd
        7.8.1 4D Pharma Research Ltd Details
        7.8.2 4D Pharma Research Ltd Major Business
        7.8.3 4D Pharma Research Ltd Human Microbiome Product and Services
        7.8.4 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 4D Pharma Research Ltd Recent Developments/Updates
        7.8.6 4D Pharma Research Ltd Competitive Strengths & Weaknesses
    7.9 Enterologics
        7.9.1 Enterologics Details
        7.9.2 Enterologics Major Business
        7.9.3 Enterologics Human Microbiome Product and Services
        7.9.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Enterologics Recent Developments/Updates
        7.9.6 Enterologics Competitive Strengths & Weaknesses
    7.10 Metabogen
        7.10.1 Metabogen Details
        7.10.2 Metabogen Major Business
        7.10.3 Metabogen Human Microbiome Product and Services
        7.10.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Metabogen Recent Developments/Updates
        7.10.6 Metabogen Competitive Strengths & Weaknesses
    7.11 Metabiomics
        7.11.1 Metabiomics Details
        7.11.2 Metabiomics Major Business
        7.11.3 Metabiomics Human Microbiome Product and Services
        7.11.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Metabiomics Recent Developments/Updates
        7.11.6 Metabiomics Competitive Strengths & Weaknesses
    7.12 Ritter Pharmaceuticals
        7.12.1 Ritter Pharmaceuticals Details
        7.12.2 Ritter Pharmaceuticals Major Business
        7.12.3 Ritter Pharmaceuticals Human Microbiome Product and Services
        7.12.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Ritter Pharmaceuticals Recent Developments/Updates
        7.12.6 Ritter Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Osel
        7.13.1 Osel Details
        7.13.2 Osel Major Business
        7.13.3 Osel Human Microbiome Product and Services
        7.13.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Osel Recent Developments/Updates
        7.13.6 Osel Competitive Strengths & Weaknesses
    7.14 Symberix
        7.14.1 Symberix Details
        7.14.2 Symberix Major Business
        7.14.3 Symberix Human Microbiome Product and Services
        7.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Symberix Recent Developments/Updates
        7.14.6 Symberix Competitive Strengths & Weaknesses
    7.15 Miomics
        7.15.1 Miomics Details
        7.15.2 Miomics Major Business
        7.15.3 Miomics Human Microbiome Product and Services
        7.15.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Miomics Recent Developments/Updates
        7.15.6 Miomics Competitive Strengths & Weaknesses
    7.16 Symbiotix Biotherapies
        7.16.1 Symbiotix Biotherapies Details
        7.16.2 Symbiotix Biotherapies Major Business
        7.16.3 Symbiotix Biotherapies Human Microbiome Product and Services
        7.16.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Symbiotix Biotherapies Recent Developments/Updates
        7.16.6 Symbiotix Biotherapies Competitive Strengths & Weaknesses
    7.17 MicroBiome Therapeutics LLC
        7.17.1 MicroBiome Therapeutics LLC Details
        7.17.2 MicroBiome Therapeutics LLC Major Business
        7.17.3 MicroBiome Therapeutics LLC Human Microbiome Product and Services
        7.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 MicroBiome Therapeutics LLC Recent Developments/Updates
        7.17.6 MicroBiome Therapeutics LLC Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Microbiome Industry Chain
    8.2 Human Microbiome Upstream Analysis
    8.3 Human Microbiome Midstream Analysis
    8.4 Human Microbiome Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Microbiome Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Human Microbiome Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Human Microbiome Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Human Microbiome Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Human Microbiome Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Human Microbiome Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Human Microbiome Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Human Microbiome Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Human Microbiome Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Human Microbiome Players in 2023
    Table 12. World Human Microbiome Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Human Microbiome Company Evaluation Quadrant
    Table 14. Head Office of Key Human Microbiome Player
    Table 15. Human Microbiome Market: Company Product Type Footprint
    Table 16. Human Microbiome Market: Company Product Application Footprint
    Table 17. Human Microbiome Mergers & Acquisitions Activity
    Table 18. United States VS China Human Microbiome Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Human Microbiome Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Human Microbiome Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Human Microbiome Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Human Microbiome Revenue Market Share (2019-2024)
    Table 23. China Based Human Microbiome Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Human Microbiome Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Human Microbiome Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Human Microbiome Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Human Microbiome Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Human Microbiome Revenue Market Share (2019-2024)
    Table 29. World Human Microbiome Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Human Microbiome Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Human Microbiome Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Human Microbiome Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Human Microbiome Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Human Microbiome Market Size by Application (2025-2030) & (USD Million)
    Table 35. Vedanta Basic Information, Area Served and Competitors
    Table 36. Vedanta Major Business
    Table 37. Vedanta Human Microbiome Product and Services
    Table 38. Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Vedanta Recent Developments/Updates
    Table 40. Vedanta Competitive Strengths & Weaknesses
    Table 41. Seres Therapeutics Basic Information, Area Served and Competitors
    Table 42. Seres Therapeutics Major Business
    Table 43. Seres Therapeutics Human Microbiome Product and Services
    Table 44. Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Seres Therapeutics Recent Developments/Updates
    Table 46. Seres Therapeutics Competitive Strengths & Weaknesses
    Table 47. Second Genome Basic Information, Area Served and Competitors
    Table 48. Second Genome Major Business
    Table 49. Second Genome Human Microbiome Product and Services
    Table 50. Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Second Genome Recent Developments/Updates
    Table 52. Second Genome Competitive Strengths & Weaknesses
    Table 53. Rebiotix Basic Information, Area Served and Competitors
    Table 54. Rebiotix Major Business
    Table 55. Rebiotix Human Microbiome Product and Services
    Table 56. Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Rebiotix Recent Developments/Updates
    Table 58. Rebiotix Competitive Strengths & Weaknesses
    Table 59. ActoGeniX Basic Information, Area Served and Competitors
    Table 60. ActoGeniX Major Business
    Table 61. ActoGeniX Human Microbiome Product and Services
    Table 62. ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. ActoGeniX Recent Developments/Updates
    Table 64. ActoGeniX Competitive Strengths & Weaknesses
    Table 65. Enterome BioScience Basic Information, Area Served and Competitors
    Table 66. Enterome BioScience Major Business
    Table 67. Enterome BioScience Human Microbiome Product and Services
    Table 68. Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Enterome BioScience Recent Developments/Updates
    Table 70. Enterome BioScience Competitive Strengths & Weaknesses
    Table 71. AvidBiotics Basic Information, Area Served and Competitors
    Table 72. AvidBiotics Major Business
    Table 73. AvidBiotics Human Microbiome Product and Services
    Table 74. AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. AvidBiotics Recent Developments/Updates
    Table 76. AvidBiotics Competitive Strengths & Weaknesses
    Table 77. 4D Pharma Research Ltd Basic Information, Area Served and Competitors
    Table 78. 4D Pharma Research Ltd Major Business
    Table 79. 4D Pharma Research Ltd Human Microbiome Product and Services
    Table 80. 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. 4D Pharma Research Ltd Recent Developments/Updates
    Table 82. 4D Pharma Research Ltd Competitive Strengths & Weaknesses
    Table 83. Enterologics Basic Information, Area Served and Competitors
    Table 84. Enterologics Major Business
    Table 85. Enterologics Human Microbiome Product and Services
    Table 86. Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Enterologics Recent Developments/Updates
    Table 88. Enterologics Competitive Strengths & Weaknesses
    Table 89. Metabogen Basic Information, Area Served and Competitors
    Table 90. Metabogen Major Business
    Table 91. Metabogen Human Microbiome Product and Services
    Table 92. Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Metabogen Recent Developments/Updates
    Table 94. Metabogen Competitive Strengths & Weaknesses
    Table 95. Metabiomics Basic Information, Area Served and Competitors
    Table 96. Metabiomics Major Business
    Table 97. Metabiomics Human Microbiome Product and Services
    Table 98. Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Metabiomics Recent Developments/Updates
    Table 100. Metabiomics Competitive Strengths & Weaknesses
    Table 101. Ritter Pharmaceuticals Basic Information, Area Served and Competitors
    Table 102. Ritter Pharmaceuticals Major Business
    Table 103. Ritter Pharmaceuticals Human Microbiome Product and Services
    Table 104. Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Ritter Pharmaceuticals Recent Developments/Updates
    Table 106. Ritter Pharmaceuticals Competitive Strengths & Weaknesses
    Table 107. Osel Basic Information, Area Served and Competitors
    Table 108. Osel Major Business
    Table 109. Osel Human Microbiome Product and Services
    Table 110. Osel Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Osel Recent Developments/Updates
    Table 112. Osel Competitive Strengths & Weaknesses
    Table 113. Symberix Basic Information, Area Served and Competitors
    Table 114. Symberix Major Business
    Table 115. Symberix Human Microbiome Product and Services
    Table 116. Symberix Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Symberix Recent Developments/Updates
    Table 118. Symberix Competitive Strengths & Weaknesses
    Table 119. Miomics Basic Information, Area Served and Competitors
    Table 120. Miomics Major Business
    Table 121. Miomics Human Microbiome Product and Services
    Table 122. Miomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Miomics Recent Developments/Updates
    Table 124. Miomics Competitive Strengths & Weaknesses
    Table 125. Symbiotix Biotherapies Basic Information, Area Served and Competitors
    Table 126. Symbiotix Biotherapies Major Business
    Table 127. Symbiotix Biotherapies Human Microbiome Product and Services
    Table 128. Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Symbiotix Biotherapies Recent Developments/Updates
    Table 130. MicroBiome Therapeutics LLC Basic Information, Area Served and Competitors
    Table 131. MicroBiome Therapeutics LLC Major Business
    Table 132. MicroBiome Therapeutics LLC Human Microbiome Product and Services
    Table 133. MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 134. Global Key Players of Human Microbiome Upstream (Raw Materials)
    Table 135. Human Microbiome Typical Customers
List of Figure
    Figure 1. Human Microbiome Picture
    Figure 2. World Human Microbiome Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Human Microbiome Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Human Microbiome Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Human Microbiome Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Human Microbiome Revenue (2019-2030) & (USD Million)
    Figure 13. Human Microbiome Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Human Microbiome Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Human Microbiome Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Human Microbiome by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Microbiome Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Microbiome Markets in 2023
    Figure 27. United States VS China: Human Microbiome Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Human Microbiome Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Human Microbiome Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Human Microbiome Market Size Market Share by Type in 2023
    Figure 31. Gastrointestinal Tract Human Micobiome
    Figure 32. Urogenital Tract Human Micobiome
    Figure 33. Others
    Figure 34. World Human Microbiome Market Size Market Share by Type (2019-2030)
    Figure 35. World Human Microbiome Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Human Microbiome Market Size Market Share by Application in 2023
    Figure 37. Treatment
    Figure 38. Diagnosis
    Figure 39. Human Microbiome Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC